BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17174219)

  • 1. Anticoagulants and their reversal.
    Schulman S; Bijsterveld NR
    Transfus Med Rev; 2007 Jan; 21(1):37-48. PubMed ID: 17174219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversing anticoagulants both old and new.
    Warkentin TE; Crowther MA
    Can J Anaesth; 2002; 49(6):S11-25. PubMed ID: 12557411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of bleeding complications in the anticoagulated patient.
    Bhagirath VC; O'Malley L; Crowther MA
    Semin Hematol; 2011 Oct; 48(4):285-94. PubMed ID: 22000094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reversal for heparins and new anticoagulant treatments].
    Kortchinsky T; Vigué B; Samama CM
    Ann Fr Anesth Reanim; 2013 Jan; 32(1):37-49. PubMed ID: 23273505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bleeding complications of anticoagulant therapy].
    Gumulec J; Kessler P; Procházka V; Brejcha M; Penka M; Zänger M; Machytka E; Klement P
    Vnitr Lek; 2009 Mar; 55(3):277-89. PubMed ID: 19378860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Andexanet Alfa, the Possible Alternative to Protamine for Reversal of Unfractionated Heparin.
    Maneno JN; Ness GL
    Ann Pharmacother; 2021 Feb; 55(2):261-264. PubMed ID: 32667214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation.
    Tanaka KA; Szlam F; Dickneite G; Levy JH
    Thromb Res; 2008; 122(1):117-23. PubMed ID: 17977586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant activated factor VII effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, argatroban, and bivalirudin ex vivo as measured using thromboelastography.
    Young G; Yonekawa KE; Nakagawa PA; Blain RC; Lovejoy AE; Nugent DJ
    Blood Coagul Fibrinolysis; 2007 Sep; 18(6):547-53. PubMed ID: 17762530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of drug-induced anticoagulation: old solutions and new problems.
    Dzik WS
    Transfusion; 2012 May; 52 Suppl 1():45S-55S. PubMed ID: 22578371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversing the new oral anticoagulants with prothrombin complex concentrates (PCCs): what is the evidence?
    Dickneite G; Hoffman M
    Thromb Haemost; 2014 Feb; 111(2):189-98. PubMed ID: 24136202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of coagulopathy in warfarin associated cerebral hemorrhage.
    Aiyagari V; Testai FD
    Curr Opin Crit Care; 2009 Apr; 15(2):87-92. PubMed ID: 19300085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents.
    Levi M; Eerenberg E; Kamphuisen PW
    J Thromb Haemost; 2011 Sep; 9(9):1705-12. PubMed ID: 21729240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Old and new anticoagulants. Antidotes and measures for acute hemorrhaging and urgent interventions].
    Lancé M; Stessel B; Hamulyák K; Marcus MA
    Anaesthesist; 2010 Jan; 59(1):62, 64-8. PubMed ID: 19936577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel anticoagulants and the future of anticoagulation.
    Garcia D
    Thromb Res; 2009; 123 Suppl 4():S50-5. PubMed ID: 19303505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary intervention.
    Patel AA; White CM; Coleman CI
    Conn Med; 2007 Feb; 71(2):93-5. PubMed ID: 17393902
    [No Abstract]   [Full Text] [Related]  

  • 18. Restoration of the normal coagulation process: advances in therapies to antagonize heparin.
    D'Ambra M
    J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S58-62. PubMed ID: 8938285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of asymptomatic over-anticoagulation with oral vitamin K.
    Chirputkar SK; Poole HJ; McNeil RC; Tansey P; Etherington AM; Morrison C; Tait RC
    Br J Haematol; 2006 Nov; 135(4):591-2. PubMed ID: 17054668
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.